NRC 18.75 (-0.42%)
US6373722023• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. NRC

National Research (NRC) Competitor Comparison

We are evaluating the key criteria listed to compare National Research (NRC) against its competitors in the Diagnostics & Research industry.

Market Capitalization

33 / 58

Gross Profits

35 / 52

Total Revenue

38 / 57

EBITDA

25 / 56

Free Cashflow

25 / 56

Quick Ratio

56 / 57

Earnings per Share

16 / 56

Dividend yield

3 / 9

Total Cash

55 / 57

Performance 3 years

31 / 58

Performance 5 years

44 / 58

Performance 10 years

30 / 58

Linearity 3 years

24 / 58

Linearity 5 years

39 / 58

Linearity 10 years

5 / 58

Total Rank

25 / 58

Dividend Rank

14 / 58

Valuation Rank

29 / 58

Piotroski Rank

13 / 58

Muliplier Rank

58 / 58

Linearity 10 years - NRC ranking 5 / 58

These are the competitors of National Research in the industry Diagnostics & Research ranked by linearity 10 years
1. Guardant Health GH
67.78
2. Neogen NEOG
44.88
3. Ortho Clinical Diagnostics Holdings OCDX
33.4
4. Inotiv NOTV
28.02
5. National Research NRC
14.2
6. Illumina ILMN
11.42
7. Olink Holding OLK
8.11
8. Fulgent Genetics FLGT
5.87
9. Global Cord Blood CO
5.67
10. Anixa Biosciences ANIX
5.37
11. DarioHealth DRIO
4.86
12. Pacific Biosciences of California PACB
4.58
13. Myriad Genetics MYGN
4.3
14. Sotera Health SHC
4.09
15. Syneos Health SYNH
3.71
16. Enzo Biochem ENZ
3.5
17. Qiagen QGEN
3.42
18. Exact Sciences EXAS
3.3
19. Co-Diagnostics CODX
3.21
20. Twist Bioscience TWST
3.15
21. Bioventus BVS
3.09
22. Sera Prognostics SERA
2.92
23. Psychemedics PMD
2.75
24. Aspira Womens Health AWH
2.28
25. Exagen XGN
2.22
26. NeoGenomics NEO
2.17
27. CareDx CDNA
2.15
28. Meridian Bioscience VIVO
2.1
29. MaxCyte MXCT
2.03
30. MDxHealth MDXH
2
31. Biodesix BDSX
1.93
32. Personalis PSNL
1.91
33. Prenetics Global PRE
1.81
34. Charles River Laboratories CRL
1.75
35. Organovo Holdings ONVO
1.66
36. Neuronetics STIM
1.62
37. bioAffinity Technologies BIAF
1.59
38. Trinity Biotech TRIB
1.57
39. Icon ICLR
1.46
40. SeqLL SQL
1.42
41. Quest Diagnostics DGX
1.31
42. Interpace Biosciences IDXG
1.31
43. IQVIA Holdings IQV
1.24
44. Laboratory Corp of America Holdings LH
1.19
45. Agilent Technologies A
1.15
46. PerkinElmer PKI
1.15
47. Precipio PRPO
1.05
48. DexCom DXCM
1.03
49. Mettler-Toledo MTD
0.96
50. Waters WAT
0.91
51. Thermo Fisher Scientific TMO
0.8
52. IDEXX Laboratories IDXX
0.77
53. Danaher DHR
0.73
54. Heska HSKA
0.52
55. RadNet RDNT
0.5
56. Natera NTRA
0.42
57. Lantheus Holdings LNTH
0.33
58. Medpace Holdings MEDP
0.22
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.